Join
Live feed
·
INSIDERFilingvia Quantisnow
Concert Pharmaceuticals Inc. logo

SEC Form 4: Cassella James V sold $26,522 worth of Common Stock (8,086 units at $3.28), decreasing direct ownership by 9% to 85,978 units to cover withholding tax

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CNCE (Concert Pharmaceuticals Inc.) and more on Quantisnow.